ID   EHD3_HUMAN              Reviewed;         535 AA.
AC   Q9NZN3; B4DFR5; D6W574; Q8N514; Q9NZB3;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   13-JUL-2010, sequence version 2.
DT   28-JUN-2023, entry version 176.
DE   RecName: Full=EH domain-containing protein 3 {ECO:0000305};
DE   AltName: Full=PAST homolog 3 {ECO:0000305};
GN   Name=EHD3 {ECO:0000312|HGNC:HGNC:3244};
GN   Synonyms=EHD2 {ECO:0000303|PubMed:10673336}, PAST3
GN   {ECO:0000312|HGNC:HGNC:3244};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10673336; DOI=10.1006/geno.1999.6087;
RA   Pohl U., Smith J.S., Tachibana I., Ueki K., Lee H.K., Ramaswamy S., Wu Q.,
RA   Mohrenweiser H.W., Jenkins R.B., Louis D.N.;
RT   "EHD2, EHD3, and EHD4 encode novel members of a highly conserved family of
RT   EH domain-containing proteins.";
RL   Genomics 63:255-262(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=12121420; DOI=10.1034/j.1600-0854.2002.30807.x;
RA   Galperin E., Benjamin S., Rapaport D., Rotem-Yehudar R., Tolchinsky S.,
RA   Horowitz M.;
RT   "EHD3: a protein that resides in recycling tubular and vesicular membrane
RT   structures and interacts with EHD1.";
RL   Traffic 3:575-589(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PROTEIN SEQUENCE OF 1-10, AND ACETYLATION AT MET-1.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   FUNCTION, SUBUNIT, INTERACTION WITH RAB11FIP2, ATP-BINDING SITE,
RP   MUTAGENESIS OF GLY-65; VAL-203 AND TRP-485, AND SUBCELLULAR LOCATION.
RX   PubMed=16251358; DOI=10.1091/mbc.e05-05-0466;
RA   Naslavsky N., Rahajeng J., Sharma M., Jovic M., Caplan S.;
RT   "Interactions between EHD proteins and Rab11-FIP2: a role for EHD3 in early
RT   endosomal transport.";
RL   Mol. Biol. Cell 17:163-177(2006).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=17233914; DOI=10.1186/1471-2121-8-3;
RA   George M., Ying G., Rainey M.A., Solomon A., Parikh P.T., Gao Q., Band V.,
RA   Band H.;
RT   "Shared as well as distinct roles of EHD proteins revealed by biochemical
RT   and functional comparisons in mammalian cells and C. elegans.";
RL   BMC Cell Biol. 8:3-3(2007).
RN   [9]
RP   INTERACTION WITH EHD4.
RX   PubMed=18331452; DOI=10.1111/j.1600-0854.2008.00732.x;
RA   Sharma M., Naslavsky N., Caplan S.;
RT   "A role for EHD4 in the regulation of early endosomal transport.";
RL   Traffic 9:995-1018(2008).
RN   [10]
RP   FUNCTION.
RX   PubMed=19139087; DOI=10.1242/jcs.037051;
RA   Naslavsky N., McKenzie J., Altan-Bonnet N., Sheff D., Caplan S.;
RT   "EHD3 regulates early-endosome-to-Golgi transport and preserves Golgi
RT   morphology.";
RL   J. Cell Sci. 122:389-400(2009).
RN   [11]
RP   INTERACTION WITH MICALL1.
RX   PubMed=19864458; DOI=10.1091/mbc.e09-06-0535;
RA   Sharma M., Giridharan S.S., Rahajeng J., Naslavsky N., Caplan S.;
RT   "MICAL-L1 links EHD1 to tubular recycling endosomes and regulates receptor
RT   recycling.";
RL   Mol. Biol. Cell 20:5181-5194(2009).
RN   [12]
RP   FUNCTION, INTERACTION WITH ANK2, AND SUBCELLULAR LOCATION.
RX   PubMed=20489164; DOI=10.1161/circresaha.110.216713;
RA   Gudmundsson H., Hund T.J., Wright P.J., Kline C.F., Snyder J.S., Qian L.,
RA   Koval O.M., Cunha S.R., George M., Rainey M.A., Kashef F.E., Dun W.,
RA   Boyden P.A., Anderson M.E., Band H., Mohler P.J.;
RT   "EH domain proteins regulate cardiac membrane protein targeting.";
RL   Circ. Res. 107:84-95(2010).
RN   [13]
RP   FUNCTION.
RX   PubMed=21791287; DOI=10.1016/j.neuron.2011.05.036;
RA   Kotowski S.J., Hopf F.W., Seif T., Bonci A., von Zastrow M.;
RT   "Endocytosis promotes rapid dopaminergic signaling.";
RL   Neuron 71:278-290(2011).
RN   [14]
RP   FUNCTION.
RX   PubMed=24019528; DOI=10.1074/jbc.m113.488627;
RA   Cai B., Giridharan S.S., Zhang J., Saxena S., Bahl K., Schmidt J.A.,
RA   Sorgen P.L., Guo W., Naslavsky N., Caplan S.;
RT   "Differential roles of C-terminal Eps15 homology domain proteins as
RT   vesiculators and tubulators of recycling endosomes.";
RL   J. Biol. Chem. 288:30172-30180(2013).
RN   [15]
RP   FUNCTION.
RX   PubMed=23781025; DOI=10.1242/jcs.122465;
RA   Waxmonsky N.C., Conner S.D.;
RT   "Alphavbeta3-integrin-mediated adhesion is regulated through an AAK1L- and
RT   EHD3-dependent rapid-recycling pathway.";
RL   J. Cell Sci. 126:3593-3601(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25686250; DOI=10.1038/ncb3109;
RA   Lu Q., Insinna C., Ott C., Stauffer J., Pintado P.A., Rahajeng J., Baxa U.,
RA   Walia V., Cuenca A., Hwang Y.S., Daar I.O., Lopes S.,
RA   Lippincott-Schwartz J., Jackson P.K., Caplan S., Westlake C.J.;
RT   "Early steps in primary cilium assembly require EHD1/EHD3-dependent ciliary
RT   vesicle formation.";
RL   Nat. Cell Biol. 17:228-240(2015).
RN   [18]
RP   ERRATUM OF PUBMED:25686250.
RA   Lu Q., Insinna C., Ott C., Stauffer J., Pintado P.A., Rahajeng J., Baxa U.,
RA   Walia V., Cuenca A., Hwang Y.S., Daar I.O., Lopes S.,
RA   Lippincott-Schwartz J., Jackson P.K., Caplan S., Westlake C.J.;
RL   Nat. Cell Biol. 17:531-531(2015).
RN   [19]
RP   SUMOYLATION, AND MUTAGENESIS OF LYS-315 AND LYS-511.
RX   PubMed=26226295; DOI=10.1371/journal.pone.0134053;
RA   Cabasso O., Pekar O., Horowitz M.;
RT   "SUMOylation of EHD3 Modulates Tubulation of the Endocytic Recycling
RT   Compartment.";
RL   PLoS ONE 10:E0134053-E0134053(2015).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [21]
RP   STRUCTURE BY NMR OF 433-535.
RX   PubMed=23754701; DOI=10.1007/s12104-013-9497-z;
RA   Spagnol G., Reiling C., Kieken F., Caplan S., Sorgen P.L.;
RT   "Chemical shift assignments of the C-terminal Eps15 homology domain-3 EH
RT   domain.";
RL   Biomol. NMR. Assign. 8:263-267(2014).
CC   -!- FUNCTION: ATP- and membrane-binding protein that controls membrane
CC       reorganization/tubulation upon ATP hydrolysis (PubMed:25686250). In
CC       vitro causes tubulation of endocytic membranes (PubMed:24019528).
CC       Binding to phosphatidic acid induces its membrane tubulation activity
CC       (By similarity). Plays a role in endocytic transport. Involved in early
CC       endosome to recycling endosome compartment (ERC), retrograde early
CC       endosome to Golgi, and endosome to plasma membrane (rapid recycling)
CC       protein transport. Involved in the regulation of Golgi maintenance and
CC       morphology (PubMed:16251358, PubMed:17233914, PubMed:19139087,
CC       PubMed:23781025). Involved in the recycling of internalized D1 dopamine
CC       receptor (PubMed:21791287). Plays a role in cardiac protein trafficking
CC       probably implicating ANK2 (PubMed:20489164). Involved in the
CC       ventricular membrane targeting of SLC8A1 and CACNA1C and probably the
CC       atrial membrane localization of CACNA1GG and CACNA1H implicated in the
CC       regulation of atrial myocyte excitability and cardiac conduction (By
CC       similarity). In conjunction with EHD4 may be involved in endocytic
CC       trafficking of KDR/VEGFR2 implicated in control of glomerular function
CC       (By similarity). Involved in the rapid recycling of integrin beta-3
CC       implicated in cell adhesion maintenance (PubMed:23781025). Involved in
CC       the unidirectional retrograde dendritic transport of endocytosed BACE1
CC       and in efficient sorting of BACE1 to axons implicating a function in
CC       neuronal APP processing (By similarity). Plays a role in the formation
CC       of the ciliary vesicle, an early step in cilium biogenesis; possibly
CC       sharing redundant functions with EHD1 (PubMed:25686250).
CC       {ECO:0000250|UniProtKB:Q9QXY6, ECO:0000269|PubMed:16251358,
CC       ECO:0000269|PubMed:17233914, ECO:0000269|PubMed:19139087,
CC       ECO:0000269|PubMed:21791287, ECO:0000269|PubMed:23781025,
CC       ECO:0000269|PubMed:24019528, ECO:0000269|PubMed:25686250,
CC       ECO:0000305|PubMed:20489164}.
CC   -!- SUBUNIT: Homooligomer, and heterooligomer with EHD1, EHD2 and EHD4,
CC       ATP-binding is required for heterooligomerization (PubMed:16251358,
CC       PubMed:17233914). Interacts with PACSIN1 (By similarity). Interacts
CC       with PACSIN2 (By similarity). Interacts (via EH domain) with MICALL1
CC       (PubMed:19864458). Interacts (via EH domain) with RAB11FIP2
CC       (PubMed:16251358). Interacts with ANK2 (PubMed:20489164).
CC       {ECO:0000250|UniProtKB:Q9QXY6, ECO:0000269|PubMed:16251358,
CC       ECO:0000269|PubMed:17233914, ECO:0000269|PubMed:18331452,
CC       ECO:0000269|PubMed:19864458, ECO:0000269|PubMed:20489164}.
CC   -!- INTERACTION:
CC       Q9NZN3; Q01484: ANK2; NbExp=2; IntAct=EBI-2870749, EBI-941975;
CC       Q9NZN3; Q9P2R3: ANKFY1; NbExp=3; IntAct=EBI-2870749, EBI-2513908;
CC       Q9NZN3; Q15041: ARL6IP1; NbExp=3; IntAct=EBI-2870749, EBI-714543;
CC       Q9NZN3; Q9H4M9: EHD1; NbExp=8; IntAct=EBI-2870749, EBI-490691;
CC       Q9NZN3; Q8N3F8: MICALL1; NbExp=5; IntAct=EBI-2870749, EBI-1056885;
CC       Q9NZN3; Q9QXY6: Ehd3; Xeno; NbExp=5; IntAct=EBI-2870749, EBI-775304;
CC   -!- SUBCELLULAR LOCATION: Recycling endosome membrane
CC       {ECO:0000269|PubMed:17233914}; Peripheral membrane protein
CC       {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Cell membrane
CC       {ECO:0000269|PubMed:17233914}; Peripheral membrane protein
CC       {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Cell projection, cilium
CC       membrane {ECO:0000269|PubMed:25686250}; Peripheral membrane protein
CC       {ECO:0000305}; Cytoplasmic side {ECO:0000305}. Note=Localizes to the
CC       ciliary pocket from where the cilium protrudes (PubMed:25686250).
CC       Colocalizes with RAB8A and MYO5B to a cytoplasmic tubular network
CC       devoid of RAB11A (By similarity). Colocalizes with ANK2 in myocyte
CC       perinuclear region (PubMed:20489164). Colocalizes with BACE1 in
CC       tubulovesicular cytoplasmic membranes. Colocalizes with BACE1 and APP
CC       amyloid beta proteins in hippocampal mossy fiber terminals (By
CC       similarity). {ECO:0000250|UniProtKB:Q9QXY6,
CC       ECO:0000269|PubMed:20489164, ECO:0000269|PubMed:25686250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NZN3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NZN3-2; Sequence=VSP_056606, VSP_056607;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart and brain and moderately
CC       expressed in kidney, liver, and placenta.
CC       {ECO:0000269|PubMed:10673336}.
CC   -!- DOMAIN: The EH domain interacts with Asn-Pro-Phe (NPF) motifs of target
CC       proteins. {ECO:0000250|UniProtKB:Q9WVK4}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class dynamin-like GTPase
CC       superfamily. Dynamin/Fzo/YdjA family. EHD subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU01055}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF40471.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF181264; AAF40471.1; ALT_FRAME; mRNA.
DR   EMBL; AF214736; AAF32285.1; -; mRNA.
DR   EMBL; AK294222; BAG57526.1; -; mRNA.
DR   EMBL; AK316006; BAH14377.1; -; mRNA.
DR   EMBL; AL121657; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471053; EAX00480.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00481.1; -; Genomic_DNA.
DR   CCDS; CCDS1774.1; -. [Q9NZN3-1]
DR   RefSeq; NP_055415.1; NM_014600.2. [Q9NZN3-1]
DR   AlphaFoldDB; Q9NZN3; -.
DR   BMRB; Q9NZN3; -.
DR   SMR; Q9NZN3; -.
DR   BioGRID; 119055; 29.
DR   IntAct; Q9NZN3; 12.
DR   MINT; Q9NZN3; -.
DR   STRING; 9606.ENSP00000327116; -.
DR   iPTMnet; Q9NZN3; -.
DR   MetOSite; Q9NZN3; -.
DR   PhosphoSitePlus; Q9NZN3; -.
DR   SwissPalm; Q9NZN3; -.
DR   BioMuta; EHD3; -.
DR   DMDM; 300669636; -.
DR   OGP; Q9NZN3; -.
DR   EPD; Q9NZN3; -.
DR   jPOST; Q9NZN3; -.
DR   MassIVE; Q9NZN3; -.
DR   MaxQB; Q9NZN3; -.
DR   PaxDb; Q9NZN3; -.
DR   PeptideAtlas; Q9NZN3; -.
DR   ProteomicsDB; 4072; -.
DR   ProteomicsDB; 83458; -. [Q9NZN3-1]
DR   Antibodypedia; 29084; 178 antibodies from 29 providers.
DR   DNASU; 30845; -.
DR   Ensembl; ENST00000322054.10; ENSP00000327116.5; ENSG00000013016.16. [Q9NZN3-1]
DR   GeneID; 30845; -.
DR   KEGG; hsa:30845; -.
DR   MANE-Select; ENST00000322054.10; ENSP00000327116.5; NM_014600.3; NP_055415.1.
DR   UCSC; uc002rnu.4; human. [Q9NZN3-1]
DR   AGR; HGNC:3244; -.
DR   CTD; 30845; -.
DR   DisGeNET; 30845; -.
DR   GeneCards; EHD3; -.
DR   HGNC; HGNC:3244; EHD3.
DR   HPA; ENSG00000013016; Tissue enhanced (brain, esophagus).
DR   MIM; 605891; gene.
DR   neXtProt; NX_Q9NZN3; -.
DR   OpenTargets; ENSG00000013016; -.
DR   PharmGKB; PA27679; -.
DR   VEuPathDB; HostDB:ENSG00000013016; -.
DR   eggNOG; KOG1954; Eukaryota.
DR   GeneTree; ENSGT00940000159274; -.
DR   HOGENOM; CLU_017595_1_1_1; -.
DR   InParanoid; Q9NZN3; -.
DR   OMA; LMIGQYS; -.
DR   OrthoDB; 12127at2759; -.
DR   PhylomeDB; Q9NZN3; -.
DR   TreeFam; TF314429; -.
DR   PathwayCommons; Q9NZN3; -.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SignaLink; Q9NZN3; -.
DR   BioGRID-ORCS; 30845; 12 hits in 1149 CRISPR screens.
DR   ChiTaRS; EHD3; human.
DR   GenomeRNAi; 30845; -.
DR   Pharos; Q9NZN3; Tbio.
DR   PRO; PR:Q9NZN3; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9NZN3; protein.
DR   Bgee; ENSG00000013016; Expressed in lateral nuclear group of thalamus and 172 other tissues.
DR   Genevisible; Q9NZN3; HS.
DR   GO; GO:0020018; C:ciliary pocket membrane; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:GOC.
DR   GO; GO:0005769; C:early endosome; IBA:GO_Central.
DR   GO; GO:0030139; C:endocytic vesicle; IBA:GO_Central.
DR   GO; GO:0010008; C:endosome membrane; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0055038; C:recycling endosome membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:InterPro.
DR   GO; GO:0003676; F:nucleic acid binding; TAS:ProtInc.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0034498; P:early endosome to Golgi transport; IMP:UniProtKB.
DR   GO; GO:0032456; P:endocytic recycling; IDA:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; IBA:GO_Central.
DR   GO; GO:0090160; P:Golgi to lysosome transport; IMP:UniProtKB.
DR   GO; GO:1901387; P:positive regulation of voltage-gated calcium channel activity; IEA:Ensembl.
DR   GO; GO:0051260; P:protein homooligomerization; IPI:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IGI:MGI.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0001881; P:receptor recycling; IMP:UniProtKB.
DR   GO; GO:1903779; P:regulation of cardiac conduction; IEA:Ensembl.
DR   GO; GO:0086036; P:regulation of cardiac muscle cell membrane potential; IGI:MGI.
DR   GO; GO:0055117; P:regulation of cardiac muscle contraction; IEA:Ensembl.
DR   GO; GO:1903358; P:regulation of Golgi organization; IMP:UniProtKB.
DR   CDD; cd00052; EH; 1.
DR   CDD; cd09913; EHD; 1.
DR   Gene3D; 1.10.268.20; -; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR040990; DUF5600.
DR   InterPro; IPR045063; Dynamin_N.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR000261; EH_dom.
DR   InterPro; IPR031692; EHD_N.
DR   InterPro; IPR030381; G_DYNAMIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11216; EH DOMAIN; 1.
DR   Pfam; PF18150; DUF5600; 1.
DR   Pfam; PF00350; Dynamin_N; 1.
DR   Pfam; PF12763; EF-hand_4; 1.
DR   Pfam; PF16880; EHD_N; 1.
DR   SMART; SM00027; EH; 1.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
DR   PROSITE; PS50031; EH; 1.
DR   PROSITE; PS51718; G_DYNAMIN_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Calcium; Cell membrane;
KW   Cell projection; Cilium; Cilium biogenesis/degradation; Coiled coil;
KW   Direct protein sequencing; Endosome; Isopeptide bond; Membrane;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Protein transport;
KW   Reference proteome; Transport; Ubl conjugation.
FT   CHAIN           1..535
FT                   /note="EH domain-containing protein 3"
FT                   /id="PRO_0000146112"
FT   DOMAIN          55..286
FT                   /note="Dynamin-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   DOMAIN          444..532
FT                   /note="EH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00077"
FT   DOMAIN          476..511
FT                   /note="EF-hand"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   REGION          65..72
FT                   /note="G1 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          91..92
FT                   /note="G2 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          153..156
FT                   /note="G3 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          219..222
FT                   /note="G4 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          243
FT                   /note="G5 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   COILED          198..227
FT                   /evidence="ECO:0000255"
FT   BINDING         65..72
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:16251358"
FT   BINDING         220
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BH64"
FT   BINDING         258
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BH64"
FT   BINDING         489
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         491
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         493
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         495
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         500
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000269|PubMed:12665801"
FT   MOD_RES         349
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8R491"
FT   MOD_RES         456
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QXY6"
FT   CROSSLNK        315
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000269|PubMed:26226295"
FT   CROSSLNK        511
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000269|PubMed:26226295"
FT   VAR_SEQ         169..175
FT                   /note="YDFAAVL -> PAAGPGL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056606"
FT   VAR_SEQ         176..535
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056607"
FT   MUTAGEN         65
FT                   /note="G->R: Abolishes ATP-binding and localizes to
FT                   cytoplasm."
FT                   /evidence="ECO:0000269|PubMed:16251358"
FT   MUTAGEN         203
FT                   /note="V->P: Greatly reduces oligomerization and
FT                   interaction with RAB11FIP2."
FT                   /evidence="ECO:0000269|PubMed:16251358"
FT   MUTAGEN         315
FT                   /note="K->R: Abolishes sumoylation and localization to
FT                   tubular structures of the ERC, impairs fast recycling
FT                   activity from the ERC, no effect on homooligomerization;
FT                   when associated with R-511."
FT                   /evidence="ECO:0000269|PubMed:26226295"
FT   MUTAGEN         485
FT                   /note="W->A: Abolishes interaction with RAB11FIP2."
FT                   /evidence="ECO:0000269|PubMed:16251358"
FT   MUTAGEN         511
FT                   /note="K->R: Abolishes sumoylation localization to tubular
FT                   structures of the ERC, impairs fast recycling activity from
FT                   the ERC, no effect on homooligomerization;; when associated
FT                   with R-315."
FT                   /evidence="ECO:0000269|PubMed:26226295"
SQ   SEQUENCE   535 AA;  60887 MW;  0F8AE99F84B966AD CRC64;
     MFSWLGTDDR RRKDPEVFQT VSEGLKKLYK SKLLPLEEHY RFHEFHSPAL EDADFDNKPM
     VLLVGQYSTG KTTFIRYLLE QDFPGMRIGP EPTTDSFIAV MQGDMEGIIP GNALVVDPKK
     PFRKLNAFGN AFLNRFVCAQ LPNPVLESIS VIDTPGILSG EKQRISRGYD FAAVLEWFAE
     RVDRIILLFD AHKLDISDEF SEVIKALKNH EDKMRVVLNK ADQIETQQLM RVYGALMWSL
     GKIVNTPEVI RVYIGSFWSH PLLIPDNRKL FEAEEQDLFR DIQSLPRNAA LRKLNDLIKR
     ARLAKVHAYI ISSLKKEMPS VFGKDNKKKE LVNNLAEIYG RIEREHQISP GDFPNLKRMQ
     DQLQAQDFSK FQPLKSKLLE VVDDMLAHDI AQLMVLVRQE ESQRPIQMVK GGAFEGTLHG
     PFGHGYGEGA GEGIDDAEWV VARDKPMYDE IFYTLSPVDG KITGANAKKE MVRSKLPNSV
     LGKIWKLADI DKDGMLDDDE FALANHLIKV KLEGHELPNE LPAHLLPPSK RKVAE
//
